News & Events
ChanRx Secures Series A Funding
ChanRx is developing a superior drug for treatment of atrial fibrillation (AFIB), and has closed its Series A funding...
Cardiac Safety Services
The most comprehensive and trusted pre-clinical cardiac risk assessment services [more]
Drug Discovery Services
The most complete Ion Channel & GPCR screening and profiling services [more]
